Is Bloom Energy Flying Under the Radar?
Bloom Energy (NYSE:BE) manufactures scalable fuel cells for providing on-site…
Buy
64
CADL Quote, Financials, Valuation and Earnings
Last price:
$6.74
Seasonality move
:
-18.58%
Day range:
$6.81 - $7.25
52-week range:
$3.79 - $14.60
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2,124.14x
P/B ratio:
4.64x
Volume:
1.3M
Avg. volume:
1M
1-year change:
5.33%
Market cap:
$346.7M
Revenue:
--
EPS (TTM):
-$1.34
Earnings Data
Next earnings date for CADL
Aug 13
2025
Most recent earnings per share
$0.13
Beat by $0.37
(May 13/2025)
Consensus Estimate
-$0.24
(May 13/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CADL Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | -- | -- | -- | -$0.17 | -- |
| 08/13/2025 | Q2 | -- | -- | -- | -$0.18 | -- |
| 05/13/2025 | Q1 | -- | -- | $0.13 | -$0.24 | $0.37 |
| 03/13/2025 | Q4 | -- | -- | -$0.40 | -$0.23 | -$0.17 |
| 11/14/2024 | Q3 | -- | -- | -$0.33 | -- | -- |
| 08/13/2024 | Q2 | -- | -- | -$0.74 | -- | -- |
| 05/14/2024 | Q1 | -- | -- | -$0.28 | -- | -- |
| 03/28/2024 | Q4 | -- | -- | -$0.38 | -- | -- |
| 11/09/2023 | Q3 | -- | -- | -$0.29 | -- | -- |
| 08/10/2023 | Q2 | -- | -- | -$0.33 | -$0.37 | $0.04 |
| 05/11/2023 | Q1 | -- | -- | -$0.30 | -- | -- |
| 03/30/2023 | Q4 | -- | $31K | -$0.18 | -- | -- |
| 11/10/2022 | Q3 | -- | $31K | -$0.30 | -- | -- |
| 08/05/2022 | Q2 | -- | $31K | -$0.14 | -- | -- |
| 05/12/2022 | Q1 | -- | $31K | -$0.03 | -- | -- |
| 03/29/2022 | Q4 | -- | $31K | $0.06 | -- | -- |
| 11/12/2021 | Q3 | -- | $31K | -$0.69 | -- | -- |
| 09/08/2021 | Q2 | -- | $31K | -$0.69 | -- | -- |
| 03/31/2021 | Q1 | -- | $31K | -$0.24 | -- | -- |
| 12/31/2020 | Q4 | -- | $31K | -$0.56 | -- | -- |
| 09/30/2020 | Q3 | -- | $31K | -$0.14 | -- | -- |
| 06/30/2020 | Q2 | -- | $31K | -$0.15 | -- | -- |
| 03/31/2020 | Q1 | -- | $31K | -$0.09 | -- | -- |
Candel Therapeutics Earnings Questions
-
How Much did Candel Therapeutics Generate in Revenue Last Quarter?
Candel Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Candel Therapeutics Beat Earnings Last Quarter?
Candel Therapeutics announced earnings per share of $0.13 which represents a beat of analyst forecast a -$0.24 per share.
-
Is Candel Therapeutics Profitable?
Candel Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Candel Therapeutics EPS Next Year?
Candel Therapeutics's earnings are forecast to decrease from -$1.74 per share to -$1.14 per share next year representing a decrease of -69.54%.
-
When is Candel Therapeutics's Earnings Date?
Candel Therapeutics's next earnings date is August 13, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
80
SOC alert for Jul 18
Sable Offshore [SOC] is up 11.86% over the past day.
Buy
71
PGY alert for Jul 18
Pagaya Technologies [PGY] is up 5.56% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 0.31% over the past day.
